<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">465765017</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180323111911.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">170327e19900501xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1007/BF00141258</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)springer-10.1007/BF00141258</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Lectin-resistant variants of mouse Lewis lung carcinoma cells. I. Selection and in vivo properties</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[D. Dus, H. Debray, L. strzadala, J. Rak, H. Kusnierczyk, J. Montreuil, C. Radzikowski]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">The availability of lectin-resistant cell lines with altered carbohydrate moieties in cell surface glycoproteins and glycolipids has greatly facilitated study of the involvement of cellular glycoconjugates in tumor growth and metastasis. We present here a new animal model for metastasis study based on mouse Lewis lung carcinoma LL2 in vitro cell line [10]. From this line, five lectin-resistant variant sublines were selected with the following lectins: wheat germ agglutinin (WGAR), Ricinus communis agglutinin II (RCA IIR) and Aleuria aurantia agglutinin (AAAR). The correlation of the lectin resistance with their in vitro and in vivo growth properties, and especially lung colonizing ability, were investigated. Three WGAR variants with well-preserved tumorigenicity revealed reduced metastatic ability, both spontaneous, after subcutaneous (s.c.) administration and experimental, after intravenous (i.v.) administration. The RCA IIR variant also possessed reduced spontaneous and experimental metastatic ability, but exhibited higher growth rate of local s.c. tumors. The AAAR variant possessed reduced spontaneous metastatic ability but its ability to colonize the lungs after i.v. administration was five-fold higher than that of the parent LLZ line, whereas its tumorigenicity remained unchanged. The relative differences among WGAR variants and parent LLZ line, concerning their experimental metastatic ability, remained similar in cyclophosphamide-modified mice to those in normal recipients.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">Taylor &amp; Francis Ltd., 1990</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Dus</subfield>
   <subfield code="D">D.</subfield>
   <subfield code="u">Department of Tumor Immunology, Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53114, Wroclaw, Poland</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Debray</subfield>
   <subfield code="D">H.</subfield>
   <subfield code="u">Laboratoire de Chimie Biologique de I'Université des Sciences et Techniques de Lille Flandres-Artois (Unite Mixte de Recherche MRS no. 111), 59655 Villeneuve d'Ascq Cedex, France</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">strzadala</subfield>
   <subfield code="D">L.</subfield>
   <subfield code="u">Department of Tumor Immunology, Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53114, Wroclaw, Poland</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Rak</subfield>
   <subfield code="D">J.</subfield>
   <subfield code="u">Department of Tumor Immunology, Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53114, Wroclaw, Poland</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Kusnierczyk</subfield>
   <subfield code="D">H.</subfield>
   <subfield code="u">Department of Tumor Immunology, Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53114, Wroclaw, Poland</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Montreuil</subfield>
   <subfield code="D">J.</subfield>
   <subfield code="u">Laboratoire de Chimie Biologique de I'Université des Sciences et Techniques de Lille Flandres-Artois (Unite Mixte de Recherche MRS no. 111), 59655 Villeneuve d'Ascq Cedex, France</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Radzikowski</subfield>
   <subfield code="D">C.</subfield>
   <subfield code="u">Department of Tumor Immunology, Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53114, Wroclaw, Poland</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">Clinical &amp; Experimental Metastasis</subfield>
   <subfield code="d">Kluwer Academic Publishers</subfield>
   <subfield code="g">8/3(1990-05-01), 277-286</subfield>
   <subfield code="x">0262-0898</subfield>
   <subfield code="q">8:3&lt;277</subfield>
   <subfield code="1">1990</subfield>
   <subfield code="2">8</subfield>
   <subfield code="o">10585</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1007/BF00141258</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1007/BF00141258</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Dus</subfield>
   <subfield code="D">D.</subfield>
   <subfield code="u">Department of Tumor Immunology, Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53114, Wroclaw, Poland</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Debray</subfield>
   <subfield code="D">H.</subfield>
   <subfield code="u">Laboratoire de Chimie Biologique de I'Université des Sciences et Techniques de Lille Flandres-Artois (Unite Mixte de Recherche MRS no. 111), 59655 Villeneuve d'Ascq Cedex, France</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">strzadala</subfield>
   <subfield code="D">L.</subfield>
   <subfield code="u">Department of Tumor Immunology, Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53114, Wroclaw, Poland</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Rak</subfield>
   <subfield code="D">J.</subfield>
   <subfield code="u">Department of Tumor Immunology, Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53114, Wroclaw, Poland</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Kusnierczyk</subfield>
   <subfield code="D">H.</subfield>
   <subfield code="u">Department of Tumor Immunology, Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53114, Wroclaw, Poland</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Montreuil</subfield>
   <subfield code="D">J.</subfield>
   <subfield code="u">Laboratoire de Chimie Biologique de I'Université des Sciences et Techniques de Lille Flandres-Artois (Unite Mixte de Recherche MRS no. 111), 59655 Villeneuve d'Ascq Cedex, France</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Radzikowski</subfield>
   <subfield code="D">C.</subfield>
   <subfield code="u">Department of Tumor Immunology, Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53114, Wroclaw, Poland</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">Clinical &amp; Experimental Metastasis</subfield>
   <subfield code="d">Kluwer Academic Publishers</subfield>
   <subfield code="g">8/3(1990-05-01), 277-286</subfield>
   <subfield code="x">0262-0898</subfield>
   <subfield code="q">8:3&lt;277</subfield>
   <subfield code="1">1990</subfield>
   <subfield code="2">8</subfield>
   <subfield code="o">10585</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">Springer special CC-BY-NC licence</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-springer</subfield>
  </datafield>
 </record>
</collection>
